# Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty

> **NCT01410240** · PHASE4 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 137 (actual)

## Conditions studied

- Knee Replacement Surgery
- Osteoarthritis

## Interventions

- **PROCEDURE:** Standard of Care
- **DRUG:** FLOSEAL Hemostatic Matrix + Standard of care

## Key facts

- **NCT ID:** NCT01410240
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2014-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01410240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01410240, "Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01410240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*